PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Lobbying client · District of Columbia · filed 2025 to 2026

Biopharmaceutical industry trade association.

$240,000 Reported spend

6 Filings counted

1 Firms hired

8 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (203230), not by name.

Firms hired 1

MARSHALL & POPP, LLC $240,000 6 filings

Bills named in these filings 8

HR 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…

6 filings
S 1040
Drug Competition Enhancement Act

6 filings
S 1041
Affordable Prescriptions for Patients Act

6 filings
HCONRES 14
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth…

2 filings
HR 2882
Further Consolidated Appropriations Act, 2024

1 filing
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

1 filing
HR 7148
Consolidated Appropriations Act, 2026

1 filing
SCONRES 7
An original concurrent resolution setting forth the congressional budget for the United States Government for…

1 filing

Reported by year 2 years

2026 $80,000 2 filings
2025 $160,000 4 filings

Issues lobbied 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 6

Centers For Medicare and Medicaid Services (CMS) 6
Food & Drug Administration (FDA) 6
Health & Human Services, Dept of (HHS) 6
HOUSE OF REPRESENTATIVES 6
Natl Economic Council (NEC) 6
SENATE 6

Recent filings 6 total

Q2

MARSHALL & POPP, LLC

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $40,000 income · posted Jul 9, 2026

View → Q1

MARSHALL & POPP, LLC

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $40,000 income · posted Apr 17, 2026

View → Q4

MARSHALL & POPP, LLC

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $40,000 income · posted Jan 16, 2026

View → Q3

MARSHALL & POPP, LLC

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $40,000 income · posted Oct 20, 2025

View → Q2

MARSHALL & POPP, LLC

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $40,000 income · posted Jul 21, 2025

View → Q1

MARSHALL & POPP, LLC

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $40,000 income · posted Apr 21, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.